Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The acquisition will add peptide API development and manufacturing capabilities.
read more
Piramal Pharma Ltd (PPL) announced the addition of three members to its board of directors. The company has added Mr. Peter Stevenson, Ms. Nathalie Leitch and Mr. Sridhar Gorthi to the board.
read more
Thursday, February 01, 2024
Revenue from Operations grew by 14% YoY both in Q3FY24 and 9MFY24, driven by double digit growth across all the three businesses
read more
Thursday, November 06, 2025
Piramal Pharma announced its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2025.
read more
Tuesday, October 07, 2025
Piramal Pharma Solutions has introduced the PODs (Plan, Own, and Deliver) Project Execution System at its Aurora, Canada facility. The Aurora site implemented this innovative system to execute seamless deliveries to customers amidst a growing ...
read more
Piramal Pharma Limited has announced a $90M investment plan towards expanding two of the Company’s US facilities. These expansions are in response to ongoing demand from US customers, in support of the trend towards US onshoring of drug supply, and ...
read more
Piramal has entered into an agreement with G&W Laboratories to acquire its solid oral dosage drug product manufacturing facility located in Sellersville, Pennsylvania.
read more
Tuesday, December 16, 2025
Piramal Pharma Solutions has achieved a Net Promoter Score (NPS) of 55 for the time period representing FY2025 (April 2024 – March 2025).
read more
Tuesday, January 13, 2026
Piramal Pharma Limited (PPL) announced it achieved a score of 63 on the 2025 S&P Global CSA. This marks a substantial 15% improvement over last year’s score of 55, reflecting the company's ongoing commitment to sustainability and responsible ...
read more
Tuesday, December 08, 2020
Piramal Pharma Limited has announced plans to expand its facility in Michigan with additional capacity and new capabilities for the development and manufacturing of APIs.
read more
Tuesday, September 29, 2020
Piramal Pharma held a grand opening event at their recently acquired solid oral dosage drug product manufacturing facility located in Sellersville, Pennsylvania.
read more
Piramal Healthcare Limited [NSE: PIRHEALTH, BSE: 500302], an innovation led company, has agreed to acquire Decision Resources Group a US based company in the healthcare information segment, from Providence Equity Partners for a consideration of ...
read more
Piramal Healthcare Limited [NSE: PIRHEALTH, BSE: 500302] ("Piramal"), announced that it has signed an agreement to acquire worldwide rights to the molecular imaging research and development portfolio of Bayer Pharma AG ("Bayer") through its newly ...
read more
Wednesday, October 14, 2015
Piramal Enterprises' Pharma Solutions division, a global contract development and manufacturing organization (CDMO), has delivered its comprehensive review of the injectables market – both sterile and small molecule – for the next 5 years during its ...
read more
Wednesday, September 30, 2015
Piramal Enterprises' Pharma Solutions division, a global contract development and manufacturing (CDMO) company, has set a target of becoming the market leader in ADCs contract commercialization over the next five years.
read more